MOTS-C is a mitochondria-derived peptide that has captured significant attention in metabolic and longevity research circles, and its delivery via nasal spray formats has opened new laboratory investigation pathways. First identified in 2015 by researchers at the University of Southern California, MOTS-C is encoded within the mitochondrial genome — a distinction that makes it biologically unique among known peptides. Studies have explored its role in regulating insulin sensitivity, skeletal muscle glucose uptake, and systemic energy metabolism, positioning it as one of the more intriguing compounds in contemporary mitochondrial biology research.
As nasal spray delivery formats have become increasingly common in peptide research, MOTS-C has been formulated and studied through this route for its potential to bypass first-pass metabolism and provide more direct systemic access. This guide examines the current state of preclinical MOTS-C research, what laboratory models have revealed about its mechanisms, and why researchers studying metabolic dysfunction and aging biology continue to prioritize it in 2026.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied. MOTS-C is not approved for human use and is intended strictly for in vitro and preclinical research applications.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Epithalon - 10MG
$50.00$37.50 with 1st order
Frequently Asked Questions
What is MOTS-C and where does it come from?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a microprotein encoded within the mitochondrial genome’s 12S rRNA region. It is one of the few known peptides of mitochondrial origin and has been studied for its role in regulating metabolic homeostasis, glucose utilization, and cellular energy balance in preclinical models.
What has research shown about MOTS-C and insulin sensitivity?
Preclinical studies have investigated MOTS-C’s ability to improve insulin sensitivity by activating the AMPK signaling pathway and promoting glucose uptake in skeletal muscle tissue. Animal model studies have observed improvements in insulin-mediated glucose disposal, making it a subject of interest in metabolic dysfunction research.
Why is nasal spray delivery being studied for MOTS-C?
Nasal delivery routes have been investigated because they may bypass hepatic first-pass metabolism, potentially improving bioavailability. The nasal mucosa offers a rich vascular network and proximity to the central nervous system, which researchers are exploring in terms of systemic and neurological access.
How does MOTS-C relate to aging research?
Studies have shown that circulating MOTS-C levels decline with age in both animal and human observational data. Research in aged mouse models has investigated whether exogenous MOTS-C administration can restore metabolic markers associated with younger phenotypes, including muscle energy utilization and systemic glucose regulation.
What is the relationship between MOTS-C and exercise biology?
Research has suggested that MOTS-C levels rise in response to exercise in preclinical models, leading investigators to study it as a potential mediator of exercise-induced metabolic benefits. Some researchers classify it informally as an “exercise mimetic” candidate due to its AMPK-activating properties.
Is MOTS-C the same as NAD+ or MOTS-C compounds?
MOTS-C is a distinct peptide, not to be confused with NAD+ or other mitochondrial support molecules. While both are studied in the context of mitochondrial biology and metabolic health, they operate through different mechanisms. Researchers studying mitochondrial function often examine both independently. For comparison, the MOTS-C vs NAD+ research comparison breaks down the mechanistic differences in detail.
What models have been used in MOTS-C research?
MOTS-C has been investigated primarily in murine (mouse and rat) models, including high-fat diet-induced obesity models, diet-induced insulin resistance models, and aged rodent models. In vitro studies using skeletal muscle cell lines have also been used to examine AMPK activation and glucose transporter (GLUT4) translocation.
Where can researchers source MOTS-C nasal spray for laboratory use?
MOTS-C nasal spray for research purposes is available from specialty peptide suppliers. Researchers should ensure they are sourcing from suppliers that provide certificates of analysis and purity documentation. For laboratory research use only.
MOTS-C: Origin and Mitochondrial Biology Context
The discovery of MOTS-C challenged the long-held assumption that the mitochondrial genome encodes only a limited set of proteins involved in oxidative phosphorylation. When Lee et al. published their foundational 2015 paper in Cell Metabolism, it established that the 12S rRNA region of mitochondrial DNA could produce a biologically active 16-amino-acid peptide with systemic metabolic effects — a finding that substantially expanded our understanding of mitochondrial signaling.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Epithalon - 10MG
$50.00$37.50 with 1st order
MOTS-C belongs to a broader family of mitochondria-derived peptides (MDPs) that includes Humanin and the SHLP series. What distinguishes MOTS-C among this class is its primary site of action: skeletal muscle and systemic metabolic regulation, rather than neuroprotection, which is more closely associated with Humanin. Researchers have noted that MOTS-C appears to act both in a cell-autonomous manner (affecting the cells that produce it) and as a circulating signal that influences distant tissues — a characteristic that makes it relevant to systemic metabolic research designs.
AMPK Pathway Activation: The Core Mechanism Under Study
The most consistently observed mechanism in MOTS-C research is activation of AMP-activated protein kinase (AMPK), often described as the cellular “energy sensor.” Studies have shown that MOTS-C promotes AMPK phosphorylation in skeletal muscle, which in turn stimulates GLUT4 glucose transporter translocation to the cell membrane — a process critical to insulin-independent glucose uptake. This mechanism is of significant interest to researchers modeling type 2 diabetes and metabolic syndrome in preclinical settings.
Additionally, MOTS-C research has intersected with the folate cycle, with some studies suggesting the peptide partially exerts its effects by interfering with the de novo purine synthesis pathway, leading to AICAR accumulation — a known endogenous AMPK activator. This indirect AMPK activation pathway represents a mechanistic distinction that separates MOTS-C from direct AMPK agonists and provides researchers with a unique angle of investigation.
MOTS-C 10MG Nasal Spray for research →
Metabolic Research Findings in Preclinical Models
Animal model studies examining MOTS-C have produced a consistent pattern of findings related to metabolic regulation. In high-fat diet mouse models, MOTS-C administration has been associated with resistance to diet-induced obesity and improved glucose tolerance. Researchers have observed reductions in fat mass, improved insulin sensitivity as measured by glucose tolerance tests, and changes in skeletal muscle gene expression profiles consistent with enhanced oxidative metabolism.
One particularly studied area involves the relationship between MOTS-C and aging. Circulating MOTS-C levels have been observed to decline with age in both murine and human cross-sectional data, and aged mouse models have been used to investigate whether exogenous MOTS-C can restore metabolic parameters. Studies in aged mice have explored whether MOTS-C administration improves physical performance metrics and metabolic flexibility — parameters that typically diminish during normal aging processes.
Exercise Biology and the “Exercise Mimetic” Research Question
A compelling area of MOTS-C investigation involves its apparent relationship with physical exercise. Studies have reported that plasma MOTS-C levels rise transiently in response to acute exercise in both rodent and human observational data, suggesting the peptide may function as a myokine-like signaling molecule that mediates some of exercise’s downstream metabolic benefits. This has led some researchers to categorize MOTS-C research questions alongside those of other potential exercise mimetic compounds, such as SLU-PP-322, though their mechanisms differ substantially.
Preclinical exercise intervention studies have used MOTS-C to investigate whether exogenous supplementation can potentiate exercise-related metabolic adaptations, including mitochondrial biogenesis markers, improved insulin signaling cascades, and skeletal muscle lipid oxidation rates. These studies remain at early stages and primarily involve animal models.
Longevity and Cellular Stress Response Research
Beyond metabolic regulation, MOTS-C has been studied in the context of cellular stress responses and longevity biology. Research has investigated the peptide’s nuclear translocation capabilities — some studies have shown MOTS-C can translocate from the mitochondria to the nucleus under conditions of cellular stress, where it may regulate stress-response gene expression. This nuclear activity is an area of active inquiry and suggests MOTS-C functions as a retrograde mitochondrial signaling molecule with broader transcriptional influence than initially appreciated.
This intersection of mitochondrial biology and longevity research positions MOTS-C within the same general research category as other compounds studied for their effects on metabolic aging, including NAD+ precursors and mitophagy-regulating compounds. Researchers exploring the biology of aging frequently examine multiple mitochondrial regulators in parallel to understand their respective contributions to metabolic decline.
NAD+ 500MG Nasal Spray for research →
Nasal Spray Delivery Format: Research Considerations
The emergence of nasal spray delivery for MOTS-C in research contexts reflects a broader trend toward non-injectable administration routes that researchers have been studying across multiple peptide classes. As discussed in the context of delivery method comparisons for research peptides, each route presents distinct pharmacokinetic considerations that affect how studies are designed and how results are interpreted.
For MOTS-C specifically, intranasal delivery has been studied for several theoretical advantages. The nasal mucosa presents a highly vascularized surface area that may facilitate rapid absorption into systemic circulation without hepatic first-pass processing. Additionally, the proximity of the nasal cavity to the olfactory bulb and the central nervous system has led some researchers to investigate whether intranasally administered MOTS-C achieves CNS distribution, which would be relevant to neurodegenerative disease research models.
Formulation Stability and Laboratory Handling
Peptide stability is a critical consideration in research protocols involving MOTS-C. As a 16-amino-acid peptide, MOTS-C is susceptible to enzymatic degradation in biological environments. Researchers handling MOTS-C nasal spray formulations are advised to review stability data for their specific formulation, including storage temperature requirements (typically -20°C for lyophilized forms), reconstitution protocols, and freeze-thaw cycle limitations. Understanding the distinction between lyophilized peptide formats and pre-reconstituted solutions is important for maintaining compound integrity across a study duration.
Nasal spray presentations intended for research use are typically formulated in sterile aqueous carriers with appropriate pH buffering. Researchers should verify purity certificates (HPLC ≥98% is standard for research-grade material) and mass spectrometry confirmation when sourcing MOTS-C for controlled laboratory studies.
MOTS-C 10MG Nasal Spray — research grade →
MOTS-C in the Context of Related Metabolic Peptide Research
Researchers studying metabolic function often examine MOTS-C alongside other peptides with overlapping but distinct mechanisms. The GLP peptide family — including GLP-1, GLP-2, and GLP-3 analogs — represents another major area of metabolic peptide research, though these compounds operate through entirely different receptor systems (incretin signaling vs. mitochondrial AMPK pathways). Understanding how these research areas intersect and diverge helps researchers design more comprehensive metabolic study panels.
Within the mitochondrial peptide category specifically, MOTS-C is often compared to Humanin and the SHLP series. Each of these MDPs exhibits tissue-specific activity profiles, and researchers studying systemic metabolic regulation have found MOTS-C to be the most peripherally active of the group, while Humanin studies have focused more heavily on neuroprotection and cellular apoptosis inhibition.
Combination Research Considerations
Some research programs have begun investigating MOTS-C in combination with other metabolic and regenerative peptides. For instance, research teams studying muscle metabolism have explored whether MOTS-C’s AMPK activation might synergize with growth hormone secretagogues such as those investigated in CJC-1295 and Ipamorelin combination studies, given that GH signaling and AMPK pathways both influence skeletal muscle protein synthesis and energy metabolism. These combination studies remain exploratory and are conducted exclusively in preclinical models.
CJC-1295 No DAC + Ipamorelin 10MG Nasal Spray for research →
Where These Fit in Your Research Library
Researchers building a comprehensive mitochondrial and metabolic peptide research library may find the following products relevant:
- MOTS-C 10MG Nasal Spray — primary mitochondria-derived peptide for metabolic and longevity studies
- NAD+ 500MG Nasal Spray — complementary mitochondrial coenzyme research compound
- 5-Amino-1MQ 50MG — NNMT inhibition and metabolic research compound
Browse the full catalog at SourcePeptides.co for additional research-grade peptides with certificates of analysis.
Final Takeaway: MOTS-C Research in 2026
MOTS-C nasal spray research represents one of the more scientifically grounded areas of contemporary peptide investigation. Its mitochondrial origin, AMPK-activating mechanism, and consistent preclinical findings in metabolic dysfunction and aging models have established it as a peptide of significant interest for researchers studying energy metabolism, insulin biology, and longevity pathways. The nasal spray delivery format adds an additional dimension of investigation, with researchers examining whether transmucosal delivery can provide reproducible systemic and potentially CNS-accessible exposure profiles.
As the field of mitochondrial peptide biology continues to expand — with additional MDPs being characterized and functional studies accumulating — MOTS-C is likely to remain a central research compound. Its unique position as a mitochondrially-encoded circulating signal places it at the intersection of organelle biology, systems metabolism, and aging science, making it a high-value compound for research programs focused on any of these areas in 2026 and beyond. All research using MOTS-C should be conducted in appropriate preclinical models by qualified investigators in compliance with institutional research guidelines.
Sources & Further Reading
- Lee C et al. — “The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance” — Cell Metabolism (2015)
- Reynolds JC et al. — “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis” — Nature Communications (2021)
- Kim SJ et al. — “Mitochondrially derived peptides as novel regulators of metabolism” — Journal of Physiology (2017)
- Zempo H et al. — “A naturally occurring human MOTS-c variant adversely affects mitochondrial stress response” — Scientific Reports (2021)
- PubMed Search — MOTS-C peptide metabolism research (current literature)
